Figure 2.
Summary of the main pro-angiogenic factors (VEGF, FGF, PDGF, and EGF), their corresponding receptors (VEGFR, FGFR, PDGFR, and EGFR), and targeted angiogenic inhibitors currently in clinical trials for pancreatic cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.